Brazil Decrees Gilead’s Tenofovir In ‘Public Interest’
Apr 17th 2008Drug InformationHIV / AIDS
Brazil’s Ministry of Health on Wednesday issued a decree signaling that it might reject Gilead’s patent request for its antiretroviral drug tenofovir due to its high cost and import a generic version of the drug, Reuters reports.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
